HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFN alpha 2a and Ribavirin: a randomized controlled trial

Colombatto, P ; Brunetto, M R ; Maina, A M ; Romagnoli, V ; Almasio, P ; Rumi, M G ; Ascione, A ; Pinzello, G ; Mondelli, M ; Muratori, L ; Rappuoli, R ; Rosa, D ; Houghton, M ; Abrignani, S ; Bonino, F

Journal of viral hepatitis, 2014-07, Vol.21 (7), p.458-465 [Periódico revisado por pares]

Texto completo disponível